David Dai is an accomplished professional in the field of clinical pharmacology with extensive experience in quantitative systems pharmacology. Currently serving as Associate Director in Clinical Pharmacology Oncology at GSK since January 2025, David has held significant roles at AstraZeneca and Pfizer, including Associate Director of Clinical and Quantitative Pharmacology and Sr. Scientist. Prior to these positions, David gained research experience at Cornell University as a Research Assistant and contributed to Pfizer's Internal Medicine Research Unit as a Systems Modeler. David's background also includes operational management at Cornell's Big Red Barn. Academic credentials feature a PhD in Chemical Engineering from Cornell University and a BS in Chemical Engineering from the University of Maryland Baltimore County.
This person is not in any teams
This person is not in any offices